Rare thyroid non-neoplastic diseases

被引:11
作者
Lacka K. [1 ]
MacIejewski A. [1 ]
机构
[1] Department of Endocrinology, Metabolism and Internal Medicine, University of Medical Sciences, Poznan
关键词
Congenital hypothyroidism; Dysgenesis; Dyshormonogenesis; Mutation; Rare disease; Thyroid gland; Thyroid hormone resistance; Thyroxin binding globulin; Transthyretin;
D O I
10.1186/s13044-015-0017-3
中图分类号
学科分类号
摘要
Rare diseases are usually defined as entities affecting less than 1 person per 2,000. About 7,000 different rare entities are distinguished and, among them, rare diseases of the thyroid gland. Although not frequent, they can be found in the everyday practice of endocrinologists and should be considered in differential diagnosis. Rare non-neoplastic thyroid diseases will be discussed. Congenital hypothyroidism's frequency is relatively high and its early treatment is of vital importance for neonatal psychomotor development; CH is caused primarily by thyroid dysgenesis (85%) or dyshormonogenesis (10-15%), although secondary defects - hypothalamic and pituitary - can also be found; up to 40% of cases diagnosed on neonatal screening are transient. Inherited abnormalities of thyroid hormone binding proteins (TBG, TBP and albumin) include alterations in their concentration or affinity for iodothyronines, this leads to laboratory test abnormalities, although usually with normal free hormones and clinical euthyroidism. Thyroid hormone resistance is most commonly found in THRB gene mutations and more rarely in THRA mutations; in some cases both genes are unchanged (non-TR RTH). Recently the term 'reduced sensitivity to thyroid hormones' was introduced, which encompass not only iodothyronine receptor defects but also their defective transmembrane transport or metabolism. Rare causes of hyperthyroidism are: activating mutations in TSHR or GNAS genes, pituitary adenomas, differentiated thyroid cancer or gestational trophoblastic disease; congenital hyperthyroidism cases are also seen, although less frequently than CH. Like other organs and tissues, the thyroid can be affected by different inflammatory and infectious processes, including tuberculosis and sarcoidosis. In most of the rare thyroid diseases genetic factors play a key role, many of them can be classified as monogenic disorders. Although there are still some limitations, progress has been made in our understanding of rare thyroid diseases etiopathogenesis, and, thanks to these studies, also in our understanding of how normal thyroid gland functions. © 2015 Lacka and Maciejewski; licensee BioMed Central.
引用
收藏
相关论文
共 83 条
  • [1] Posada De La Paz M., Villaverde-Hueso A., Alonso V., Janos S., Zurriaga O., Pollan M., Et al., Rare diseases epidemiology research, Rare Diseases Epidemiology, pp. 17-40, (2010)
  • [2] Hennekam R.C., Care for patients with ultra-rare disorders, Eur J Med Genet, 54, 3, pp. 220-224, (2011)
  • [3] Rastogi M.V., LaFranchi S.H., Congenital hypothyroidism, Orphanet J Rare Dis., 5, (2010)
  • [4] Harris K.B., Pass KA Increase in congenital hypothyroidism in New York State and in the United States, Mol Genet Metab., 91, pp. 268-277, (2007)
  • [5] Zhan J.Y., Qin Y.F., Zhao Z.Y., Neonatal screening for congenital hypothyroidism and phenylketonuria in China, World J Pediatr, 5, 2, pp. 136-139, (2009)
  • [6] Kumorowicz-Czoch M., Tylek-Lemanska D., Starzyk J., Thyroid dysfunctions in children detected in mass screening for congenital hypothyroidism, J Pediatr Endocrinol Metab, 24, 3-4, pp. 141-145, (2011)
  • [7] Brown R.S., Demmer L.A., The etiology of thyroid dysgenesis-still an enigma after all these years, J Clin Endocrinol Metab, 87, 9, pp. 4069-4071, (2002)
  • [8] Ruchala M., Szczepanek E., Szaflarski W., Et al., Increased risk of thyroid pathology in patients with thyroid hemiagenesis: Results of a large cohort case-control study, Eur J Endocrinol, 162, 1, pp. 153-160, (2010)
  • [9] Kirmizibekmez H., Guven A., Yildiz M., Cebeci A.N., Dursun F., Developmental defects of the thyroid gland: Relationship with advanced maternal age, J Clin Res Pediatr Endocrinol, 4, 2, pp. 72-75, (2012)
  • [10] Jeziorowska A., Pniewska-Siark B., Brzezianska E., Pastuszak-Lewandoska D., Lewinski A., A novel mutation in the thyrotropin (thyroid-stimulating hormone) receptor gene in a case of congenital hypothyroidism, Thyroid, 16, 12, pp. 1303-1309, (2006)